Print page web address:

Back to web page (non print view)

Painful diabetic neuropathy research: participants needed

Monday, 15 Dec 2014

Painful diabetic neuropathySixteen research participants who suffer with painful diabetic neuropathy are needed for pain relief research by a physiotherapy honours student at Charles Sturt University (CSU) in Orange. Ms Gabrielle Upton said her research in the CSU School of Community Health will be conducted over 27 days in January and February 2015 with the aim to compare the pain relief effects of two different types of Transcutaneous Electrical Nerve Stimulation (TENS) for people with painful diabetic neuropathy. "The participants will have the opportunity to use a pain relief machine (TENS) for a total of 20 days with no cost to them," Ms Upton said. "Subject will be required to attend four appointments at Charles Sturt University in Orange for about 30 minutes each time. During this time it is expected that the subjects' level of pain will reduce. TENS is a safe treatment with minimal risk of adverse effects and can be used for many different types of pain. This is important research and I appreciate any assistance volunteers can provide." Ms Upton's research has CSU Ethics Committee approval and is being closely supervised by three highly qualified and experienced CSU academics. Please contact Ms Gabrielle Upton on 0427 106 498 to discuss eligibility and inclusion criteria.

Media contact: Bruce Andrews, (02) 6338 6084

Media Note:

Contact CSU Media to arrange interviews.

Research participants must have less than a ten year history of Type 2 diabetes and have experienced painful diabetic neuropathy symptoms for six months or longer. Other tools, such as recent blood test results and questionnaires, will also be used to assess eligibility.

This research offers potential benefits for patients with diabetic neuropathy and for health care workers. If one type of TENS is more effective than the other, health professionals can use choose the best type when treating patients with painful diabetic neuropathy. This will improve pain management, and could possibly be included in management guidelines for diabetes. This research might also encourage more research on pain relief treatments for painful diabetic neuropathy.

Back to web page (non print view)